重度宫腔粘连分离术后不同方法预防再粘连的比较研究

目的:比较重度宫腔粘连宫腔镜下宫腔粘连切除术(TCRA)后预防再次粘连的3种治疗方法的临床疗效。方法:选择2005年1月1日至2014年12月31日于绵阳市中心医院行TCRA的重度宫腔粘连患者共计157例。分为3组:几丁糖组51例,术后宫腔注入几丁糖2 ml;IUD组50例,术后放置IUD;几丁糖+IUD组56例,术后宫腔注入几丁糖同时放置IUD;几丁糖组及几丁糖+IUD组术后均安置阴道隔膜24小时,术后3个月宫腔镜下观察宫腔情况。结果:几丁糖组、IUD组、几丁糖+IUD组3组预防宫腔再粘连有效率分别为47.1%、32.0%及64.3%,3组比较差异有统计学意义(P=0.004);再粘连率分别为86.3%、92.0%及69.6%,3组比较差异有统计学意义(P=0.007)。结论:TCRA术后宫腔注入几丁糖与放置IUD联合应用,可明显提高宫腔粘连治疗有效率,降低术后再次粘连的发生。     

中重度宫腔粘连术后放置COOK球囊和宫内节育器的疗效分析

目的:探讨中重度宫腔粘连(IUA)患者行宫腔镜下粘连分解术后放置COOK球囊及宫内节育器(IUD)后的月经改善、预防粘连复发及生育方面的疗效。方法:选取142例中重度宫腔粘连患者,随机分为COOK球囊组(65例)和IUD组(77例)。COOK球囊组:宫腔粘连分解术后放置COOK球囊,术后1周取出COOK球囊,术后1月再次行宫腔镜下探查术;IUD组:宫腔粘连分解术后放置元宫型IUD,术后1月取出并行宫腔镜下探查术。术后随访两组患者的粘连复发、月经改善及妊娠率。结果:COOK球囊组和IUD组的粘连复发率分别为12.3%(8/65)和27.3%(21/77),月经有效率分别为84.6%(55/65)和70.1%(54/77),两组比较差异均有统计学意义(P=0.036,P=0.048)。COOK球囊组和IUD组的术后妊娠率分别为61.5%(40/65)和53.2%(41/77),差异均无统计学意义(P=0.395)。结论:中重度IUA患者在宫腔镜粘连分解术后,放置COOK球囊比元宫型IUD能更有效地预防粘连复发和改善月经,术后妊娠率无明显差别。     

中重度宫腔粘连分离术后预防宫腔再粘连的临床效果观察

目的:探讨中重度宫腔粘连分离术后预防宫腔再粘连的临床效果。方法:回顾性分析2013年1月至2014年6月在武汉大学人民医院就诊的119例经宫腔镜检查确诊为中重度宫腔粘连并行TCRA术患者的临床资料。术后宫腔放置Foley球囊导尿管+宫内节育器为A组,宫腔放置Foley球囊导尿管+宫内节育器+可吸收医用膜为B组,术后均使用人工周期。比较患者的术后月经改善、宫腔及妊娠情况。结果:中度宫腔粘连患者中,B组的治愈率高于A组(57.7%vs 31.0%,P=0.047),宫腔再粘连率低于A组(15.4%vs 44.8%,P=0.018);A、B组的妊娠率分别为40%、60%,差异无统计学意义(P=0.37)。重度宫腔粘连患者中,B组的治愈率高于A组(43.8%vs 18.8%,P=0.031),宫腔再粘连率低于A组(15.6%vs 46.9%,P=0.007);A、B组的妊娠率分别为11.1%和33.3%,差异无统计学意义(P=0.257)。结论:中重度宫腔粘连分离术后联合使用Foley球囊导尿管+宫内节育器+可吸收医用膜治疗效果优于Foley球囊导尿管+宫内节育器组。     

防粘连膜联合宫内节育器用于宫腔粘连的效果分析

目的:探讨防粘连膜联合宫内节育器用于宫腔粘连治疗的效果及临床价值。方法:选择2012年1月至2016年12月哈尔滨医科大学附属第一医院收治的宫腔粘连患者55例,行宫腔镜下宫腔粘连切除术后,根据术后不同预防粘连方式分为观察组(25例)和对照组(30例)。观察组患者采用防粘连膜+宫内节育器,对照组患者采用宫内节育器。比较两组患者治疗后宫腔恢复情况、月经改善情况及妊娠情况。结果:观察组患者术后3个月宫腔粘连治疗的有效率为96.0%,对照组患者有效率为73.3%,两组相比差异有统计学意义(P0.05)。观察组患者月经恢复有效率为88.0%,对照组患者为60.0%,两组相比差异有统计学意义(P0.05)。观察组患者妊娠率为36.0%,对照组患者为36.7%,两组相比差异无统计学意义(P0.05)。结论:防粘连膜联合宫内节育器用于宫腔粘连行宫腔镜下宫腔粘连切除术后患者,可明显降低宫腔再粘连的发生,改善月经情况,具有一定临床价值。     

COOK球囊联合医用几丁糖预防重度宫腔粘连术后再次宫腔粘连的临床分析

目的:探讨宫腔镜下重度宫腔粘连分离术后宫腔放置COOK球囊联合医用几丁糖对再次宫腔粘连的预防作用。方法:选择2013年6月至2016年6月在嘉兴市妇幼保健院治疗的重度宫腔粘连90例患者为研究对象,A组宫腔粘连分离术后宫腔放置医用几丁糖(30例),B组术后宫腔放置COOK球囊(30例),C组术后宫腔放置几丁糖加COOK球囊(30例),3组患者术后均人工周期修复内膜。术后2个月行二次宫腔探查,比较3组患者宫腔恢复情况、AFS评分改善率,半年后评估月经改善情况。结果:二次宫腔探查时A组再次宫腔粘连率为63.33%,B组再次宫腔粘连率为60.00%,C组再次宫腔粘连率为33.33%,A、B组间比较差异无统计学意义(P0.05),C组与A、B组比较差异有统计学意义(P0.05)。3组术后AFS评分改善率分别为(55.3±21.1)%、(55.5±21.7)%、(67.6±18.3)%,A、B组间比较差异无统计学意义(P0.05),C组与A、B组比较差异有统计学意义(P0.05)。3组月经改善率分别为66.67%,70.00%,93.33%,A、B组间比较差异无统计学意义(P0.05),C组与A、B组比较,差异有统计学意义(P0.05)。结论:宫腔放置COOK球囊联合医用几丁糖的综合治疗方案能够有效预防重度宫腔粘连术后再次宫腔粘连,改善月经。     

冷刀分离宫腔粘连术后妊娠结局相关因素分析

目的:探讨冷刀分离宫腔粘连术后影响妊娠结局的相关因素。方法:回顾分析158例行冷刀分离宫腔粘连术患者的临床资料,对可能影响妊娠结局的相关因素进行单因素和多因素Logistic回归分析,包括年龄、病程、宫腔操作次数、术前月经、术后月经、是否曾电切、粘连范围、粘连类型、粘连程度、防粘连措施、再粘连与否。结果:158例患者行冷刀分离粘连后,月经改善率80.3%,总妊娠率为60.1%,活产率为55.8%。病程、术后月经、粘连范围、粘连类型、粘连程度、再粘连与妊娠结局有关(P0.05),年龄、宫腔操作次数、术前月经、曾电切、防粘连装置与妊娠结局无关(P0.05)。多因素Logistic回归分析显示,再粘连是影响妊娠结局的独立危险因素。结论:冷刀作为一种对子宫内膜和宫腔环境损伤小的手术方式,可能成为有生育要求的宫腔粘连患者的首要选择。病程、术后月经、粘连范围、粘连类型、粘连程度、再粘连是影响冷刀分离粘连术后妊娠结局的主要因素。     

7～8mm宫腔镜在重度宫腔粘连分离术后预防再粘连中的应用

目的评估重度宫腔粘连分离术后应用7～8mm宫腔镜定期监测在预防官腔再粘连中所起的作用。方法回顾性分析浙江省宁波市第六医院2009年6月至2012年5月宫腔镜下重度宫腔粘连分离术102例患者的临床资料,术后官腔先放置充水球囊后放IUD者53例为球囊放环组;闭经者术后每2周实施1次7～8mm宫腔镜监测,月结来潮者在月经干净3～7d监测1次官腔粘连情况,共49例为宫腔镜监测组。观察宫腔再粘连情况,并跟踪月经改善及妊娠情况。结果术后3个月球囊放环组官腔镜探查再次粘连率为26．42％,宫腔镜监测组为6．12％（P〈0．01）;两组月经改善情况分别为81.13％和95．92％（P〈0．05）;球囊放环组妊娠率33．96％,宫腔镜监测组妊娠率38．78％,差异无统计学意义（P〉0．05）。结论重度宫腔粘连分离术后应用7～8mm宫腔镜定期监测可以有效预防再粘连,提高月经改善率,但未能显著提高妊娠率。     

宫腔镜子宫中隔切除术后3种治疗方法预防宫腔粘连的疗效及生殖预后观察

目的:探讨宫腔镜下子宫中隔切除(transcervical resection of septum,TCRS)术后预防宫腔粘连形成及改善妊娠结局的最佳治疗方案。方法:TCRS术后患者116例随机分为4组:A组(n=30),术后行人工周期;B组(n=31),术后宫腔放置宫内节育器(IUD);C组(n=27),术后放置IUD+行人工周期;D组(n=28),术后不采取任何干预措施。术后3个月再次行宫腔镜检查,观察宫腔是否发生粘连及粘连分布,随访至术后24个月,记录月经恢复情况及妊娠结局。结果:A组排除9例(6例失访,3例漏服药物),B组排除6例(4例失访,2例IUD脱落),C组排除2例(1例失访,1例IUD下移),D组排除5例(均为失访)。4组术后3个月宫腔粘连发生率依次为:14.2%(1/7)、37.5%(3/8)、22.2%(2/9)、9.1%(1/11);随访至术后24个月,妊娠率分别为:33.3%(7/21)、32.0%(8/25)、36.0%(9/25)、47.8%(11/23);流产率分别为:4.8%(1/21)、12.0%(3/25)、8.0%(2/25)、4.3%(1/23),宫腔粘连发生率、妊娠率和流产率组间均无统计学差异(P>0.05)。结论:TCRS术后进行人工周期、IUD、IUD+人工周期3种治疗方法对防止宫腔粘连形成及提高妊娠率、改善妊娠结局方面无明显益处,且治疗效果差别不大,术后不必将其作为常规治疗方法。     

加用防粘连膜的综合方法治疗重度宫腔粘连的临床效果观察

目的:探讨加用防粘连膜(Interceed)的综合治疗方法治疗重度宫腔粘连的临床效果.方法:34例重度宫腔粘连患者,随机分成2组.A组行宫腔镜下宫腔粘连分离术(TCRA),分离后放置宫内节育器(IUD),术后口服大剂量戊酸雌二醇(E2V) 10 mg/d;B组亦先行TCRA,在放置IUD同时置入Interceed,术后治疗同A组.3个月后再次行宫腔镜检查术,评估对宫腔粘连的治疗效果.结果:B组的完全治愈率高于A组(A、B组分别为0.0％、47.4％,P=0.002),宫腔再粘连率低于A组(A、B组分别为100.0％、52.6％,P=0.002),其治疗总有效率明显优于A组(A、B组分别为66.7％、100.0％,P=0.000).A、B两组的妊娠率分别为13.33％(2/15)、10.53％ (2/19),两组妊娠率差异无统计学意义(P =0.804).结论:加用Intrceed的综合治疗方法治疗重度宫腔粘连一次分离术后的疗效优于传统综合治疗方法.     

防宫腔粘连隔离器在宫腔粘连治疗中的应用及疗效分析

目的:探讨防宫腔粘连隔离器(简称隔离器)用于宫腔粘连分离术后预防再粘连的有效性及安全性,评价隔离器在宫腔粘连分离术后维持宫腔正常形态的优势。方法:选取2015年8月至2017年2月在南京医科大学第一附属医院接受治疗的中重度宫腔粘连(宫腔粘连评分≥5分)患者60例。将患者随机分为隔离器组30例(宫腔粘连分离术后宫腔放置隔离器)和宫内节育器组30例(术后宫腔放置Tcu380宫内节育器),两组患者术后均行雌孕激素序贯治疗,4周后行二次宫腔镜探查术。比较两组患者的宫腔粘连评分下降情况、月经改善情况、妊娠结局及放置后副反应,所有患者术后随访2年。结果:隔离器组患者的宫腔粘连评分术前(9.5±2.0)分,二次宫腔探查时(0.7±1.0)分,差异有统计学意义(P<0.01);节育器组术前(8.7±1.9)分,二次宫腔探查时(3.7±2.7)分,差异有统计学意义(P<0.01);隔离器组二次宫腔探查时宫腔粘连评分明显小于节育器组评分,差异有统计学意义(P<0.01)。隔离器组和节育器组二次宫腔探查时宫腔粘连评分≥5分发生率分别为0(0/30)和43%(13/30),两组比较差异有统计学意义(P<0.01);月经改善率分别为60%(18/30)和47%(14/30),两组比较差异无统计学意义(P=0.301)。随访2年,隔离器组和节育器组的妊娠率比较,差异均无统计学意义(47%vs 43%,P=0.795)。隔离组和节育器组的术后阴道出血时间比较,差异均无统计学意义[(6±3)天vs (5±2)天,P=0.078]。两组患者术后均未出现发热、泌尿生殖道感染、过敏反应、腹痛、子宫穿孔、隔离器或节育器下移或脱落、带器妊娠等副反应。结论:隔离器用于中重度宫腔粘连分离术后预防宫腔再粘连无明显副反应,在维持术后宫腔正常形态及减少术后再粘连方面有独特优势,在术后月经恢复方面及妊娠结局的改善方面与节育器组无显著差异。     

宫腔粘连的预防方法研究进展

宫腔粘连是导致不孕症的妇科常见病之一,严重危害育龄期女性生育功能及心理健康,妊娠期宫腔操作是主要原因。其发病率随宫腔操作机会增加而升高。宫腔镜检查是诊断金标准,宫腔镜下宫腔粘连分离术（transcervical resection of uterine adhesions,TCRA）是治疗的标准术式,轻度宫腔粘连治疗效果好,但中、重度宫腔粘连治疗效果欠佳,复发率高。预防宫腔粘连的方法众多,有预防性使用抗生素、口服雌激素、宫腔内注入透明质酸钠、放置宫内节育器或球囊支架等,现尚无统一标准。宫腔粘连治疗多采用TCRA+防粘连材料+人工周期的综合治疗方案,效果较单纯宫腔镜下宫腔粘连分离术好。     

宫腔粘连术后应用三腔导管负压冲洗引流装置的临床疗效观察

目的:探讨宫腔三腔导管负压冲洗引流装置在宫腔镜下宫腔粘连分离术(TCRA)后的应用效果。方法:选择收集2017年8月至2018年8月在郑州大学第三附属医院就诊并经宫腔镜检查确诊为中、重度宫腔粘连,近期有生育要求并愿意治疗和随访的患者60例,随机数字法分为两组:A组30例,术后放置宫腔三腔导管负压冲洗引流装置治疗;B组30例术后放置二腔球囊导管治疗。观察时间为术后6个月。比较两组患者术后再粘连率、内膜恢复情况、月经评分及妊娠率。结果:在二次宫腔镜探查时A组有效率为93.3%,B组为83.4%,差异均有统计学意义(P<0.05);再粘连率分别为6.7%及16.7%。术后6个月A组内膜厚度及术后经量评分中位数值均高于B组,差异有统计学意义(P<0.05);术后6个月两组妊娠率差异无统计学意义(P>0.05);两组阴道总引流液量差异有统计学意义(P<0.05),而宫腔感染率、脱管率差异无统计学意义(P>0.05)。结论:宫腔镜下宫腔粘连分离术后应用宫腔三腔导管负压冲洗引流装置相比普通二腔球囊,可降低患者再粘连率,增加患者子宫内膜厚度,改善月经情况。     

156例宫腔镜下子宫纵隔切除术后的生殖预后

目的探究和分析宫腔镜下子宫纵隔切除术(TCRS)的手术指征及生殖预后。方法采用回顾性研究方法,选择北京市平谷区医院及首都医科大学附属北京天坛医院2013年1月至2019年12月接收的156例纵隔子宫患者为主要对象,所有患者均实施宫腔镜下子宫纵隔切除术治疗,术后随访2~6年,分析患者术后妊娠及分娩结局。结果(1)25例有生育要求的患者行预防性切除子宫纵隔,术后22例(88.0%)妊娠,其中16例分娩(64.0%),6例流产(24.0%);(2)术中无1例发生子宫穿孔,出血及经尿道前列腺电切(TURP)综合征。术后无妊娠期子宫破裂发生。发生宫腔粘连5例(3.2%),均为轻微粘连;(3)不孕率、自然流产、稽留流产率分别由术前的21.9%、22.8%、29.8%降至8.4%、10.8%、7.2%,足月分娩率及活产率由术前的1.8%、2.6%升至66.3%、69.9%,术后妊娠率72.5%,手术前后比较差异有统计学意义(P<0.05)。结论对于诊断为子宫纵隔并且有生育要求的患者,建议进行预防性切除子宫纵隔;宫腔镜下子宫纵隔切除手术(TCRS)微创、安全、有效,能够明显改善其妊娠结局。     

Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection

OBJECTIVE: The purpose of this study was to compare the long-term efficacy of the levonorgestrel intrauterine system and transcervical resection of the endometrium in the treatment of menorrhagia. METHODS: This study was an open, randomized 3-year trial. Patients with menorrhagia were assigned randomly to either the levonorgestrel intrauterine system (n = 30) or endometrial resection (n = 29). Pictorial blood loss assessment charts were used to measure menstrual blood loss. A pictorial blood-loss assessment chart score exceeding 75 (representing menstrual blood loss >/=60 mL) was used to diagnosis the patient as having menorrhagia. Discontinuations and cases requiring repeat operations were evaluated. RESULTS: Pictorial blood loss scores decreased from a baseline median of 261.5 (range, 60-1503) to 7 (range, 0-101; P < .001) for the levonorgestrel intrauterine system and from 311 (range, 81-2506) to 4 (range, 0-182; P < .001) for transcervical resection of the endometrium. Nineteen women of 30 using the levonorgestrel intrauterine system completed the 3-year follow-up compared with 22 of 29 for transcervical resection of the endometrium. CONCLUSION: Both treatments efficiently reduced menstrual bleeding. The high continuation rate suggests that the levonorgestrel intrauterine system is comparable with transcervical resection of the endometrium.     

宫腔粘连分离术后行鲜胚移植活产的影响因素分析

目的探究宫腔粘连分离术(TCRA)后患者接受IVF治疗的活产率及其影响因素。方法选择2014年1月至2019年12月于山东大学附属生殖医院行TCRA手术治疗后接受IVF助孕的635例宫腔粘连(IUA)患者。随访其妊娠结局,并分析可能影响活产率的因素。结果TCRA术后患者行鲜胚移植的活产率为36.7%。年龄(OR=0.930,P<0.001)、AFS评分(OR=0.898,P=0.035)、移植胚胎数(OR=1.875,P=0.001)、促性腺激素(Gn)启动量(OR=0.994,P=0.001)是活产率的独立影响因素。结论年龄、AFS评分、移植胚胎数、Gn启动量可能是活产率的独立影响因素。对于TCRA术后准备接受IVF鲜胚移植的患者,医生应根据以上因素制定个体化治疗方案。     

经阴道超声诊断不孕症常见宫腔病变的分析——300例与宫腔镜检查结果的比较

目的:探讨经阴道超声检查不孕症患者常见宫腔内疾病的发生率准确性。方法:分析300例同时接受阴道超声及宫腔镜检查的不孕症患者常见宫腔内病变,比较2种方法的各项指标。结果:所占比例最高的宫腔内病变为子宫内膜息肉,其次为宫腔粘连、宫腔畸形,最低的是子宫内膜结核;对各种常见宫腔内病变的诊断,2种检查方法符合率比较无统计学差异(P0.05)。结论:阴道超声在诊断不孕症患者中最常见的宫腔内病变是子宫内膜息肉、宫腔粘连、宫腔畸形,黏膜下肌瘤、内膜结核较少见;子宫内膜息肉、宫腔粘连中各项指标均高,最有利于开展临床工作;对诊断子宫异常增生、慢性非特异性子宫内膜炎,宫腔镜可以定位取材,明显优于阴道超声。     

Reproductive Outcomes of In Vitro Fertilization–Intracytoplasmic Sperm Injection after Transcervical Resection of Adhesions: A Retrospective Cohort Study

Study ObjectiveTo investigate pregnancy and obstetric outcomes of patients with intrauterine adhesions (IUAs) after treatment with in vitro fertilization–intracytoplasmic sperm injection (IVF-ICSI) and fresh embryo transplantation after transcervical resection of adhesions (TCRA).DesignRetrospective cohort study.SettingUniversity-based reproductive medical center.PatientsA total of 535 patients with IUAs and with a history of TCRA and 1605 matched patients without a history of IUAs underwent IVF-ICSI and received fresh embryo transfers.InterventionsBetween January 2014 and December 2018, all patients underwent IVF-ICSI treatment and received fresh embryo transfers.Measurements and Main ResultsThe patients in the TCRA group were matched with the control group according to strict criteria. Pregnancy and obstetric outcomes were compared. There were no significant differences in clinical pregnancies, ectopic pregnancies, live births, preterm births, and obstetric outcomes between the 2 groups (p >.05). However, the TCRA group had a higher risk of miscarriage than the control group (p = .048).ConclusionTCRA improved the reproductive outcomes of patients with IUAs, but the risk of miscarriage was higher than that in the general population. To avoid miscarriage, careful monitoring is critical for pregnant patients with a history of TCRA who undergo embryo transfers during IVF treatment.     

羊膜宫腔内植入+人工周期治疗中、重度宫腔粘连的安全性及有效性

目的:评价人羊膜在宫腔粘连松解术(TCRA)后置入宫腔的安全性及预付再粘连的有效性。方法:回顾性分析34例宫腔中、重度粘连的不孕患者宫腔粘连松解术后宫腔内放置表面被覆羊膜的Foley’s球囊,1周后取出,同时给予雌激素/黄体酮周期治疗。术后第1、3个月宫腔镜检查。随访观察粘连复发率,月经改善和妊娠结局。结果:12例中度粘连组(A组)和22例重度粘连组(B组)患者手术均顺利且无并发症发生,围手术期均无感染症状。A组中75%的患者和B组中45.5%的患者月经恢复正常或得到明显改善。A组无一例宫腔粘连复发,B组中11例复发。所有患者宫内妊娠率为35.3%(12/34)。结论:人羊膜+雌激素/黄体酮周期治疗安全、有效,并能预防宫腔再次粘连的有效方法。     

A syndrome of recurrent intrauterine adhesions.

Traumatic intrauterine adhesions are known to be reversible. In some cases, following lysis of adhesions we find residual adhesions on hysterography. We have studied 11 cases in whom new adhesion formation, of different type and location have recurred following curettage for lysis of adhesions or in subsequent pregnancy. In each case there were between two and five different forms of intrauterine adhesions during the course of study. In all 11 cases hypomenorrhea was a prominent symptom. On premestrual curettage a scanty amount of endometrium was removed. Their obstetric history was characterized by sterility (four cases) and repeated early abortions, spontaneous or missed. Treatment consisted of repeated curettage and placement of an IUD. Four patients who subsequently become pregnant carried pregnancy to term or near term. Intrauterine adhesions may be considered as a localized manifestation of more generalized process of endometrial fibrosis. This may explain this syndrome of recurrent intrauterine adhesions and the paradoxical phenomenon of limited adhesions being associated with amenorrhea and hypomenorrhea.     

Predisposing Factors and Treatment Outcome of Different Stages of Intrauterine Adhesions

ObjectiveTo evaluate the predisposing factors and treatment outcomes of different stages of intrauterine adhesions.MethodsWe examined the medical records of women with Asherman syndrome seen during the period of January 2000 to December 2007 at two McGill University teaching hospitals in Montreal. Data retrieved included patient’s age, menstrual pattern, fertility, factors related to intrauterine adhesions, and rates of amenorrhea and pregnancy at 12-month follow-up. The diagnosis was established by hysteroscopic examination. After confirmation of the diagnosis, the intrauterine adhesions were removed using a standard technique with a loop electrode and glycine 1.5% as distension medium. In cases with severe intrauterine adhesions, abdominal ultrasound was used to ensure that the uterine cavity was not breached. At the completion of each procedure a number 16 Foley catheter with 5 mL of normal saline in the bulb was placed in the uterine cavity and removed five days later. In addition, vaginal estradiol 17β was administered three times daily for four weeks with oral progesterone administered in the fourth week of estradiol treatment.ResultsOf 65 patients, we identified 24 with stage I intrauterine adhesions (36.9%), 30 with stage II (46.2%), and 11 with stage III (16.9%). The main reasons for referral were infertility (stage I 75%, stage II 73.3%, stage III 27.3%), and amenorrhea (stage I 25%, stage II 23.3%, stage III 72.7%). The main predisposing factor was dilatation and curettage. Of 40 patients with intrauterine adhesions related to early pregnancy curettage, 18 patients (45%) had stage I adhesions, 17 (42.5%) had stage II, and five (12.5%) had stage III. This contrasted with 10 patients who had peripartum curettage, in whom six (60%) developed stage III adhesions (P = 0.004). The rate of amenorrhea was 32.3% before adhesiolysis and 9.2% after. Among 43 women who wished to conceive, the pregnancy rate was 51.2% and the live birth rate 32.6%.ConclusionThe main reasons for referral of women with intrauterine adhesions are infertility and amenorrhea. Postpartum curettage leads to severe adhesions. The rates of pregnancy and term pregnancy among this selected group of women were similar regardless of the severity of adhesions.